Novel EGFR-Binding Molecules and Immunoconjugates Thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160060345A1
SERIAL NO

14821398

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to EGFR are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNOGEN INC830 WINTER STREET WALTHAM MA 02451

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chittenden, Thomas Sudbury, US 19 148
Park, Peter U Somerville, US 36 400
Payne, Gillian Waban, US 28 457
Rui, Lingyun Weston, US 44 495
SETIADY, Julianto Waltham, US 16 112

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation